Literature DB >> 4353636

Estrogen receptor in a human cell line (MCF-7) from breast carcinoma.

S C Brooks, E R Locke, H D Soule.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4353636

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  79 in total

1.  Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells.

Authors:  Erina Iwabuchi; Yasuhiro Miki; Yoshiaki Onodera; Yukiko Shibahara; Kiyoshi Takagi; Takashi Suzuki; Takanori Ishida; Hironobu Sasano
Journal:  Clin Exp Metastasis       Date:  2019-06-20       Impact factor: 5.150

2.  Effects of the antiestrogen toremifene on growth of the human mammary carcinoma cell line MCF-7.

Authors:  R Grenman; K M Laine; P J Klemi; S Grenman; D J Hayashida; H Joensuu
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  The intermediate conductance Ca2+-activated K+ channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors.

Authors:  J W Roy; E A Cowley; J Blay; P Linsdell
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

4.  Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.

Authors:  James A McCubrey; Melissa L Sokolosky; Brian D Lehmann; Jackson R Taylor; Patrick M Navolanic; William H Chappell; Stephen L Abrams; Kristin M Stadelman; Ellis W T Wong; Negin Misaghian; Stefan Horn; Jörg Bäsecke; Massimo Libra; Franca Stivala; Giovanni Ligresti; Agostino Tafuri; Michele Milella; Marek Zarzycki; Andrzej Dzugaj; Francesca Chiarini; Camilla Evangelisti; Alberto M Martelli; David M Terrian; Richard A Franklin; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2008-02-21

5.  Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance.

Authors:  Gregor M Balaburski; Rita C Dardes; Michael Johnson; Bassem Haddad; Fang Zhu; Eric A Ross; Surojeet Sengupta; Andres Klein-Szanto; Hong Liu; Eun Sook Lee; Helen Kim; V Craig Jordan
Journal:  Int J Oncol       Date:  2010-08       Impact factor: 5.650

6.  Mechanisms of resistance to structurally diverse antiestrogens differ under premenopausal and postmenopausal conditions: evidence from in vitro breast cancer cell models.

Authors:  Ping Fan; Wei Yue; Ji-Ping Wang; Sarah Aiyar; Yan Li; Tae-Hyun Kim; Richard J Santen
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

7.  Low content of estrogen receptors in human giant cell tumors of bone.

Authors:  M Ishibe; Y Ishibe; T Ishibashi; T Nojima; R N Rosier; J E Puzas; K Kaneda
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

8.  Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity.

Authors:  Linda Hughes; Catherine Malone; Saranya Chumsri; Angelika M Burger; Susan McDonnell
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

9.  Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells.

Authors:  R J Miksicek; Y Lei; Y Wang
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival.

Authors:  Anna M Mileo; Claudia Abbruzzese; Stefano Mattarocci; Emanuele Bellacchio; Paola Pisano; Antonio Federico; Vittoria Maresca; Mauro Picardo; Alessandra Giorgi; Bruno Maras; M Eugenia Schininà; Marco G Paggi
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.